


发文献得奖励 特价促销,"奖"享不断
Recombinant Human CD19 (C-Fc)
Catalog# BDAF0034
Product information
产品货号 | BDAF0034 |
别名 | B-Lymphocyte Antigen CD19; B-Lymphocyte Surface Antigen B4; Differentiation Antigen CD19; T-Cell Surface Antigen Leu-12; CD19 |
产品名称 | Recombinant Human CD19 (C-Fc) |
类别 | 重组蛋白 |
推荐应用 | Dependent by end user |
存储缓冲液 | Supplied as a 0.2 μm filtered solution of PBS, pH 7.4. |
Human Swissprot No. | P15391 |
参考分子量 | 80-95kDa, reducing conditions |
预测分子量 | 132.4kDa |
运输及保存条件 | Store at ≤-70°C, stable for 6 months after receipt. Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
表达系统 | human cells |
内毒素 | Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. |
宿主 | human cells |
背景介绍 | CD19 is a single-pass type I membrane protein containing 2 Ig-like C2-type (immunoglobulin-like) domains. CD19 is expressed on follicular dendritic cells and B cells. In fact, it is present on B cells from earliest recognizable B-lineage cells during development to B-cell blasts but is lost on maturation to plasma cells. CD19 primarily acts as a B cell co-receptor in conjunction with CD21 and CD81. Upon activation, the cytoplasmic tail of CD19 becomes phosphorylated, which leads to binding by Src-family kinases and recruitment of PI-3 kinase. CD19 Assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. |